Skip to content

PP&E (Net) at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$342K-43.7%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.4M+60.7%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$41.62M-15.4%
Alumis Inc. logo
Alumis Inc.ALMS
$17.53M-13.7%
Incyte logo
IncyteINCY
$720.17M-5.9%

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+259%
Enterprise value$700.21M+179%
P/S159.6×+87.1×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's PP&E (net)?
DBV Technologies (DBVT) reported PP&E (net) of $9.9M in Q1 2026.
How has DBV Technologies's PP&E (net) changed year-over-year?
DBV Technologies's PP&E (net) decreased by 8.4% year-over-year, from $10.81M to $9.9M.
What is the long-term trend for DBV Technologies's PP&E (net)?
Over 5 years (2020 to 2025), DBV Technologies's PP&E (net) has grown at a -15.9% compound annual growth rate (CAGR), from $24.79M to $10.4M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.